New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics

Dementia is described as the fifth leading cause of death worldwide and Alzheimer’s disease (AD) is recognized as the most common, causing a huge impact on health costs and quality of patients’ lives. The main hallmarks that are commonly associated with the pathologic process are amyloid deposition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Riscado, Micaela, Baptista, Bruno, Sousa, Fani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471423/
https://www.ncbi.nlm.nih.gov/pubmed/34575473
http://dx.doi.org/10.3390/pharmaceutics13091397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471423/
https://www.ncbi.nlm.nih.gov/pubmed/34575473
http://dx.doi.org/10.3390/pharmaceutics13091397

Ejemplares similares